HIV DNA vaccine against clade B (Inovio)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameHIV DNA vaccine against clade B (Inovio)
Drug Alias NameDNA vaccine for prevention of HIV clade B infectionPENNVAX-B
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulantsGene transference
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals IncNational Institute Of Allergy And Infectious Diseases (Niaid)University Of Pennsylvania
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A